The Enterprise Value as of November 2024 (TTM) for Kiora Pharmaceuticals, Inc. (KPRX) is 4.55M

According to Kiora Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.55M. This represents a change of -88.93% compared to the average of 41.06M of the last 4 quarters.

Kiora Pharmaceuticals, Inc. (KPRX) Historical Enterprise Value (quarterly & annually)

How has KPRX Enterprise Value performed in the past?

The mean historical Enterprise Value of Kiora Pharmaceuticals, Inc. over the last ten years is 154.39M. The current 4.55M Enterprise Value has changed 194.40% with respect to the historical average. Over the past ten years (40 quarters), KPRX's Enterprise Value was at its highest in in the December 2014 quarter at 377.84M. The Enterprise Value was at its lowest in in the September 2024 quarter at 9.86M.

Kiora Pharmaceuticals, Inc. (KPRX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Kiora Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Kiora Pharmaceuticals, Inc. (KPRX) Average Enterprise Value

How has KPRX Enterprise Value performed in the past?

The current Enterprise Value of Kiora Pharmaceuticals, Inc. (KPRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Kiora Pharmaceuticals, Inc. (KPRX) Enterprise Value vs. Peers

How is KPRX’s Enterprise Value compared to its peers?

Kiora Pharmaceuticals, Inc.’s Enterprise Value is less than Virax Biolabs Group Limited (5.36M), less than Blue Water Vaccines, Inc. (8.67M), greater than Revelation Biosciences, Inc. (-3300245.00), greater than Hillstream BioPharma, Inc. (1.48M), greater than Quoin Pharmaceuticals, Ltd. (-162664.00), greater than Allarity Therapeutics, Inc. (-11495345.00), less than Kiromic BioPharma, Inc. (13.48M), greater than Biodexa Pharmaceuticals Plc (-2820215.62), less than Unicycive Therapeutics, Inc. (23.47M), less than Cardio Diagnostics Holdings, Inc. (9.47M), greater than PaxMedica, Inc. Common Stock (757.99K), less than Panbela Therapeutics, Inc. (4.75M), greater than Palisade Bio, Inc. (-4438971.00),

Build a custom stock screener for Kiora Pharmaceuticals, Inc. (KPRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kiora Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kiora Pharmaceuticals, Inc. (KPRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kiora Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.